|
Rasool, Nabila; LaRochelle, William; Zhong, Haihong et al. (2010) Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells. Clin Cancer Res 16:600-9
|
|
von Rosenvinge, Erik C; Gopal, Lakshmi D; Heller, Theo et al. (2009) Rectal fistulae resulting from treatment with sorafenib and bevacizumab. Gastrointest Endosc :
|
|
Alessandro, Riccardo; Fontana, Simona; Giordano, Margherita et al. (2008) Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia. J Cell Physiol 215:111-21
|
|
Posadas, Edwin M; Liel, Meghan S; Kwitkowski, Virginia et al. (2007) A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer 109:1323-30
|
|
Posadas, Edwin M; Kwitkowski, Virginia; Kotz, Herbert L et al. (2007) A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling. Cancer 110:309-17
|
|
Azad, Nilofer S; Rasool, Nabila; Annunziata, Christina M et al. (2006) Proteomics in clinical trials and practice: present uses and future promise. Mol Cell Proteomics 5:1819-29
|
|
Dahut, William L; Lakhani, Nehal J; Gulley, James L et al. (2006) Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther 5:22-7
|
|
Balkwill, Frances R; Ashworth, Alan; Bast, Robert C et al. (2006) 10th Biennial Helene Harris Memorial Trust meeting. Cancer Res 66:2904-6
|
|
Davidson, Ben; Espina, Virginia; Steinberg, Seth M et al. (2006) Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 12:791-9
|
|
Stevens, Ellen V; Raffeld, Mark; Espina, Virginia et al. (2005) Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma. Cancer 103:2313-9
|
Showing the most recent 10 out of 23 publications
